We are live on ! Find out more
RVNC

Revance Therapeutics, Inc.
RVNC

Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

1 hedge funds and large institutions have $425K invested in Revance Therapeutics, Inc. in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 173 → 1 (-172)

100% less capital invested

Capital invested by funds: $249M → $425K (-$249M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$26.1M
2
BCM
Beryl Capital Management
California
-$18M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$17.1M
4
OBAM
ODDO BHF Asset Management
France
-$15.5M
5
Fidelity International
Fidelity International
Bermuda
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
151
Allworth Financial
California
– -$1.77K -484 Closed
AAP
152
Arax Advisory Partners
Colorado
– -$1.45K -476 Closed
Comerica Bank
153
Comerica Bank
Texas
– -$1.29K -426 Closed
CIA
154
Cape Investment Advisory
Georgia
– -$1.06K -350 Closed
Daiwa Securities Group
155
Daiwa Securities Group
Japan
– -$1K -331 Closed
MCM
156
MAI Capital Management
Ohio
– -$912 -300 Closed
GWM
157
Geneos Wealth Management
Colorado
– -$736 -242 Closed
S
158
SignatureFD
Georgia
– -$714 -235 Closed
Amundi
159
Amundi
France
– -$773 -228 Closed
CWM
160
CarsonAllaria Wealth Management
Illinois
– -$593 -195 Closed
RIL
161
Rothschild Investment LLC
Illinois
– -$517 -170 Closed
AF
162
Atala Financial
California
– -$441 -145 Closed
CWC
163
Carolinas Wealth Consulting
North Carolina
– -$341 -112 Closed
SCM
164
Sterling Capital Management
North Carolina
– -$322 -106 Closed
SIS
165
Strategic Investment Solutions
Illinois
– -$879 -100 Closed
SO
166
STRS Ohio
Ohio
– -$304 -100 Closed
SS
167
SBI Securities
Japan
– -$258 -85 Closed
FFA
168
Farther Finance Advisors
California
– -$243 -80 Closed
CIBC Private Wealth Group
169
CIBC Private Wealth Group
Georgia
– -$132 -39 Closed
Northwestern Mutual Wealth Management
170
Northwestern Mutual Wealth Management
Wisconsin
– -$61 -20 Closed
EWA
171
EverSource Wealth Advisors
Alabama
– -$21 -7 Closed
3 4 5 6
7

RVNC Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q1 2025, worth a combined $425K — down 100% from $249M a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of RVNC and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $26.1M sold.

  • 1 institutional investor held Revance Therapeutics, Inc. (RVNC) as of Q1 2025, down from 173 in Q4 2024.
  • Funds reported $425K of Revance Therapeutics, Inc. stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Revance Therapeutics, Inc. positions in Q1 2025 and 170 closed out, a net change of -170 holders.
  • The largest Revance Therapeutics, Inc. seller in Q1 2025 was BlackRock, an estimated $26.1M sold.

Based on aggregated 13F filings for Q1 2025.